Company
DT-Axis Co., Ltd.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
DT Axis is developing a smartphone app–based digital therapeutics (DTx) program to support the treatment of depression, grounded in cognitive behavioral principles. Its flagship product, Lifton D®, received manufacturing and marketing approval from Japan's Ministry of Health, Labour and Welfare in August 2025, becoming the first DTx program in Japan approved as an adjunctive treatment for depression. The company is currently preparing for commercial launch through medical institutions while continuing to generate additional clinical evidence.
Loading relationship preview